Taken together, the results are consistent with a novel biological role for the neurosteroid PregS that acts at picomolar concentrations to intensify the intracellular response to glutamatergic signaling at synaptic, but not extra-synaptic, NMDARs by differentially augmenting CREB activation. This provides a genomic signal transduction mechanism by which PregS could participate in memory consolidation of relevance to cognitive function.
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Introduction
The neurosteroid pregnenolone sulfate (PregS) has been known to act as a cognitive enhancer and modulator of neurotransmission for 20 years, yet aligning its pharmacological and physiological effects with reliable measurements of endogenous local concentrations has remained elusive (reviewed in Gibbs et al., 2006; Schumacher et al., 2008) . Recent findings highlight the potential for neurosteroid treatment of neurological and neuropsychiatric disorders (Bibb et al., 2010; Collingridge et al., 2013) via the action of a pregnenolone (PREG) metabolite(s) including PregS (Marx et al., 2009) . PREG is synthesized de novo in the brain from cholesterol and is enriched in nervous tissue compared to its levels in cerebrospinal fluid, serum and/or plasma in both humans and rodents (Weill-Engerer et al., 2002; Marx et al., 2006 Marx et al., , 2009 Naylor et al., 2008; Caruso et al., 2013) . PREG or one of its metabolites has also emerged as a negative feedback modulator of cannabinoid receptor subtype-1 signaling (Vallée et al., 2014) , raising the possibility that neurosteroids could be viable therapeutics for the treatment of cannabis intoxication. PREG improves cognitive deficits associated with schizophrenia in a way that correlates inversely with the lowest concentrations of its downstream neurosteroid metabolites in serum, including PregS, PREG, and allopregnanolone (Marx et al., 2009; Ritsner et al., 2010 Ritsner et al., , 2014 Kreinin et al., 2014) . PregS enhances the performance of MOL #94128 5 relevant concentrations. PregS enhances excitatory synaptic transmission by both presynaptic and postsynaptic mechanisms with potencies in the micromolar range (Wu et al., 1991; Park-Chung et al., 1997; Wagner et al., 2008) . PregS, but not PREG, potentiates NMDAR responses (Wu et al., 1991 , Malayev et al. 2002 , enhances NMDAR trafficking to the cell surface (Kostakis et al., 2013 ) via a Ca 2+ dependent Gprotein coupled mechanism, and enhances LTP (Sliwinski et al., 2004; Chen et al., 2007) in an NMDAR dependent fashion. It is also known that PregS can be released in a retrograde messenger-like fashion to increase presynaptic glutamate release (Mameli et al., 2005) .
We sought to determine whether physiologically relevant concentrations of PregS could initiate a sequence of molecular events that potentially lead to cognitive per frame using a 40x water immersion objective. Regions of interest were selected for morphologically identified cells using Zeiss Axiovert software to determine changes in fluorescence intensity with a dynamic range of 0-255. The effect of drug application was quantified as the ratio of peak fluorescence above baseline during saline vs drug
Both cortical and hippocampal neurons exhibited spontaneous sEPSCs, bursting firing patterns consistent with action potentials, and oscillations of firing rate indicative of effective synaptic local network function. Oscillatory network activity in cortical and hippocampal cultures that exceeded 20% of baseline average had to be excluded from use as it was not possible to identify a true baseline level of the F/F0. Neuronal cultures were subject to three criteria for inclusion in the study: (1) ongoing network activity as judged by oscillatory fluctuations in F0 with some spiking activity were required, however, as noted above, (2) the average baseline slow waves were within 20% of F0, and (3) individual neurons were responsive to depolarization with 50 mM KCl (at least 40% over baseline).
In experiments designed for western blot analysis, sister cultures for each study group were first screened by confocal microscopy as described above. To validate the measurements, cortical cells were exposed 50 mM KCl resulting in a significant increase in pCREB (relative to CREB) of ~ 90% when compared to VEH (p<0.05, unpaired ttest). Experimental groups in which sister slices showed an increase in pCREB relative to CREB following 50 mM KCl treatment were determined to have passed the basic criteria for signal transduction, i.e., that pCREB could be formed by the cells, and thus the experimental group was included in the analysis. When any part of plating failed either MOL #94128 8 the network activity test or signal transduction test all parts of the experiment were excluded from analysis.
Rat hippocampal brain slices: Adult male Sprague Dawley rats aged P16--P30
were housed at room temperature in a light--controlled room with free access to food and water. The rats were anesthetized using isoflurane and decapitated. The brain was removed during dissection, while the head was submerged in ice--cold (4--5°C) artificial cerebrospinal fluid (aCSF), which was oxygenated with a gas mixture of 95% O2/5% CO2.The aCSF contained (in mM): 2.5 KCl, 1.25 NaH2PO4, 10 MgSO4, 0.5 CaCl2, 234 sucrose, 11 glucose, and 26 NaHCO3, pH = 7.4 (310 Osm). Hemisected coronal slices (400 µm) containing the hippocampus were cut on a Leica vibratome and transferred to a recording chamber containing oxygenated aCSF at room temperature. This aCSF contained (in mM): 126 NaCl, 2.5 KCl, 1.25 NaH2PO4, 1
MgSO4, 2 CaCl2, 10 glucose, and 26 NaHCO3, pH = 7.4 (310 Osm). Brain slices were allowed to recover for 1 hour before recording/drug treatment and then placed in a submerged thermostat--controlled recording chamber (28--29°C), which was continuously perfused with oxygenated aCSF at a flow rate of 2 ml/min. Technology, MA), 1 mM PMSF, protease+phosphatase inhibitors cocktail (Roche), 1 mM Na 3 VO 4 , 1 mM NaF). The resuspended pellet was incubated at 4°C for 15 min, centrifuged at 13,000 rpm for 10 min at 4°C, and the supernatant processed by Western blot.
Proteins were resolved under reducing conditions (100 mM DTT) using SDS-PAGE and transferred to nitrocellulose membranes (Invitrogen, CA). Membranes were incubated in anti-sera raised against phospho-CREB (pCREB) or CREB (both 1:1000;
Cell Signaling, MA) followed by incubation in HRP-conjugated secondary antibody
(1:2000; Santa Cruz Biotechnology, CA). Blots were stripped and incubated in anti-sera raised against β-actin (1:30,000; Sigma-Aldrich, MO) followed by incubation in peroxidase-conjugated secondary antibody (1:15,000; Vector Laboratories, CA), and visualized using ECL Plus (GE Healthcare, WI).
Drugs: Steroids (Steraloids (RI)) were prepared as stock solutions in DMSO and were estimated by nonlinear logistic regression using GraphPad Prism.
Results
We previously reported the phenomenon of delayed onset potentiation of the NMDAR response by PregS and that this was a Ca (Fig. 1e) . Doseresponse analysis with PregS concentrations ranging from 500 fM to 5 nM yields an EC50 of 2 pM ( Fig. 2a) , which is about six orders of magnitude more potent than PregS (Wu et al., 1991) (Fig. 3c,d ). PregS-induced [Ca 2+ ] i increase requires Ca 2+ L , and induces CREB phosphorylation (pCREB) in primary cultured cortical neurons and hippocampal brain slices ( Fig. 4a-c whether the effect of PregS on pCREB exhibits similar structural specificity, the effects of PAS, PAHS, and PregHS were tested. Only PregHS reproduced the effect of PregS, confirming the requirement for B-ring saturation. In addition, neither dehydroepiandrosterone (DHEA) nor its sulfate ester, DHEAS, increased pCREB (Fig.   4b ). This result indicates that while B-ring saturation is required, a C3 negative charge alone is not sufficient to confer neuroactive steroid-pCREB activity, and that additional structural constraints such as the length of the C-17 group may also play a role in PregS activation of pCREB.
Activation of glutamate receptors can lead to calmodulin (CaM) activation (Bading et al., 1993) and subsequent CaM kinase II (CaMKII) phosphorylation of CREB (Fukunaga and Miyamoto, 2000) . However, the CaMKII inhibitor KN93 (0.25 µM) (Sumi et al., 1991) did not abolish PregS-induced increases in pCREB (Fig. 5a) Alternatively, the MAPK signaling pathway may be activated by NMDARs or by Ca (Fig   5b) . PregS also induces an increase in the ratio of phospho-ERK (pERK) to total ERK (Fig. 5c) determine if PregS-induced pCREB increases are dependent on action potentials the cultures were treated with TTX prior to PregS application, which eliminated PregSinduced elevations of pCREB (Fig. 6a) . Synaptic NMDAR activation leads to increased pCREB, whereas extrasynaptic NMDAR activation leads to pCREB dephosphorylation (Hardingham et al., 2002) . We hypothesized that selective blockade of synaptic NMDARs should block the effect of PregS on pCREB while avoiding extrasynaptic NMDAR-mediated disinhibition of pCREB activation. Prior to PregS application, we blocked GABA A Rs using bicuculline (BIC) that instantaneously induces synaptic glutamate release via disinhibition. The activated NMDARs were blocked with MK-801, leaving only extrasynaptic NMDARs activatable (Hardingham et al., 2002) . We determined that synaptic NMDAR inhibition blocked PregS-induced pCREB increases (Fig. 6b) , indicating dependence upon synaptic but not extrasynaptic NMDAR activity.
The effects of PregS on excitatory synaptic transmission are modeled in Figure 7 .
PregS, acting either on presynaptic glutamate release or at post-synaptic receptors enhances NMDAR signaling and pCREB activation contingent upon a MAPK signal transduction pathway.
Discussion
PregS at µM concentrations enhances NMDA-induced membrane current (Wu et al., 1991) and increases [Ca 2+ ] i (Irwin et al., 1992) ; however, it is unlikely that PregS at micromolar concentrations occur naturally in widespread brain regions as bulk concentrations of PregS in rat and human brain occur at low-nM or sub-nM levels (Liere et al., 2004) . However, a recent study using an improved method of mass-spectrometry without solvolysis found bulk levels as high as 25 nM in rat hippocampus and 11 nM in This article has not been copyedited and formatted. The final version may differ from this version. (Weaver et al., 2000) , but the EC 50 for PregS potentiation of [Ca 2+ ] i is over 6 orders of magnitude lower (higher potency), which argues for a distinct binding site. On the other hand, PregS is lipophilic and charged so the observed potency could be substantially enhanced if PregS accesses its recognition site from within or at the lipid bilayer.
This leaves the intriguing possibility that a single novel receptor might trigger diverse downstream cellular signaling events by coupling to NMDARs, GPCRs, and Ca This article has not been copyedited and formatted. The final version may differ from this version. 
